Welcome to our dedicated page for Barclays Plc SEC filings (Ticker: BCLYF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Barclays PLC (BCLYF) SEC filings page on Stock Titan aggregates the company’s U.S. regulatory disclosures, with AI-powered tools to help interpret complex banking documents. Barclays files as a foreign issuer on Form 20-F and uses Form 6-K to furnish information originally released to The London Stock Exchange, covering topics that range from capital strength to share capital changes.
For users tracking Barclays’ capital position, the filings include a detailed statement on the Bank of England’s 2025 bank capital stress test. This disclosure presents common equity Tier 1, Tier 1 capital, total capital and leverage ratios, along with explanations of how these measures are defined under the UK Capital Requirements Regulation and the PRA Rulebook. AI-generated summaries can highlight the key ratios and what they imply for the bank’s resilience under stress scenarios.
Investors interested in equity structure and dilution can review multiple 6-K reports on transactions in Barclays’ own ordinary shares. These filings describe share buy-back programmes, daily purchases on the London Stock Exchange, the intention to cancel repurchased shares and the resulting issued share capital and total voting rights. Stock Titan’s interface, combined with AI, can make it easier to follow how these programmes affect outstanding shares over time.
This page also surfaces notifications of transactions by persons discharging managerial responsibilities and persons closely associated with them, which detail insider dealings in ordinary shares and American Depositary Shares. In addition, a Form 25 filing by the New York Stock Exchange LLC documents the removal from listing and/or registration of Barclays’ 4.375% Fixed Rate Senior Notes due 2026. Real-time updates from EDGAR, together with AI explanations, help users navigate these filings without reading every technical paragraph.
Barclays PLC reported that all resolutions at its Annual General Meeting were approved by shareholders. Key items included receiving the 2025 directors’ and auditors’ reports, approving the 2025 remuneration report, and reappointing all named directors and KPMG LLP as auditors.
Shareholders renewed authorities for the board to allot shares and equity securities, including in relation to contingent Equity Conversion Notes, and to conduct limited non-pre‑emptive issues and sales of treasury shares. They also authorised share repurchases, political donations and shorter notice periods for general meetings. Turnout on the poll was about 70% of the issued share register, with most resolutions receiving more than 95% of votes cast in favour. As of the AGM record time, there were 13,634,596,267 ordinary shares in issue.
Barclays PLC reported that all resolutions at its Annual General Meeting were approved by shareholders. Key items included receiving the 2025 directors’ and auditors’ reports, approving the 2025 remuneration report, and reappointing all named directors and KPMG LLP as auditors.
Shareholders renewed authorities for the board to allot shares and equity securities, including in relation to contingent Equity Conversion Notes, and to conduct limited non-pre‑emptive issues and sales of treasury shares. They also authorised share repurchases, political donations and shorter notice periods for general meetings. Turnout on the poll was about 70% of the issued share register, with most resolutions receiving more than 95% of votes cast in favour. As of the AGM record time, there were 13,634,596,267 ordinary shares in issue.
Barclays PLC has disclosed share transactions by two senior executives. Global Co-Head of Investment Banking Taylor Wright disposed of 200,000 ordinary shares at £4.179 per share on 5 May 2026 and a further 200,000 shares at £4.428 per share on 6 May 2026, on the London Stock Exchange.
Group Chief Risk Officer Taalib Shaah disposed of 500,000 ordinary shares at £4.417 per share on 6 May 2026, executed by Computershare Investor Services plc as administrator of Barclays’ nominee service, also on the London Stock Exchange.
Barclays PLC has disclosed share transactions by two senior executives. Global Co-Head of Investment Banking Taylor Wright disposed of 200,000 ordinary shares at £4.179 per share on 5 May 2026 and a further 200,000 shares at £4.428 per share on 6 May 2026, on the London Stock Exchange.
Group Chief Risk Officer Taalib Shaah disposed of 500,000 ordinary shares at £4.417 per share on 6 May 2026, executed by Computershare Investor Services plc as administrator of Barclays’ nominee service, also on the London Stock Exchange.
Barclays PLC reports a share transaction by a senior executive. Group Human Resources Director Tristram Roberts, classified as a person discharging managerial responsibilities, disposed of 200,000 ordinary shares of Barclays PLC, each with a nominal value of 25 pence.
The shares were sold at a price of £4.239 per share on the London Stock Exchange (XLON) on 29 April 2026. The transaction was executed by Computershare Investor Services plc acting as administrator of Barclays’ nominee service, and is being publicly disclosed in line with regulatory requirements.
Barclays PLC reports a share transaction by a senior executive. Group Human Resources Director Tristram Roberts, classified as a person discharging managerial responsibilities, disposed of 200,000 ordinary shares of Barclays PLC, each with a nominal value of 25 pence.
The shares were sold at a price of £4.239 per share on the London Stock Exchange (XLON) on 29 April 2026. The transaction was executed by Computershare Investor Services plc acting as administrator of Barclays’ nominee service, and is being publicly disclosed in line with regulatory requirements.
Barclays PLC plans to commence a new share buy-back programme to repurchase up to £500m of ordinary shares. The programme will start on the London business day immediately after completion of the ongoing £1,000m buy-back that began on 11 February 2026 and will end no later than 24 October 2026, subject to regulatory approval.
Barclays has appointed J.P. Morgan Securities plc to execute on-market purchases as riskless principal under pre-set parameters, using the repurchase authority granted at the 7 May 2025 AGM. All shares bought will be cancelled to reduce the company’s share capital.
Barclays PLC plans to commence a new share buy-back programme to repurchase up to £500m of ordinary shares. The programme will start on the London business day immediately after completion of the ongoing £1,000m buy-back that began on 11 February 2026 and will end no later than 24 October 2026, subject to regulatory approval.
Barclays has appointed J.P. Morgan Securities plc to execute on-market purchases as riskless principal under pre-set parameters, using the repurchase authority granted at the 7 May 2025 AGM. All shares bought will be cancelled to reduce the company’s share capital.
Barclays PLC reported solid results for the three months ended 31 March 2026, with income of £8.2bn, profit before tax of £2.8bn and attributable profit of £1.9bn. Return on equity was 11.8% and return on tangible equity 13.5%, while basic EPS rose to 14.1p.
The bank announced a new share buyback of up to £500m, in addition to an ongoing £1bn programme, and reiterated 2026 and 2028 financial targets, including Group RoTE of greater than 12% in 2026 and greater than 14% in 2028. Total income grew 6% year-on-year, helped by higher net interest income and stronger performance in Global Markets and US consumer cards.
Credit impairment charges increased to £823m, giving a Group loan loss rate of 74bps, including a £0.2bn single-name charge in the investment bank and higher provisions for UK motor finance redress, which lifted the related provision to £430m. The CET1 ratio stood at 14.1%; including the new buyback, it would be 13.9%, at the top of the stated 13–14% target range.
Barclays PLC reported solid results for the three months ended 31 March 2026, with income of £8.2bn, profit before tax of £2.8bn and attributable profit of £1.9bn. Return on equity was 11.8% and return on tangible equity 13.5%, while basic EPS rose to 14.1p.
The bank announced a new share buyback of up to £500m, in addition to an ongoing £1bn programme, and reiterated 2026 and 2028 financial targets, including Group RoTE of greater than 12% in 2026 and greater than 14% in 2028. Total income grew 6% year-on-year, helped by higher net interest income and stronger performance in Global Markets and US consumer cards.
Credit impairment charges increased to £823m, giving a Group loan loss rate of 74bps, including a £0.2bn single-name charge in the investment bank and higher provisions for UK motor finance redress, which lifted the related provision to £430m. The CET1 ratio stood at 14.1%; including the new buyback, it would be 13.9%, at the top of the stated 13–14% target range.
Barclays PLC reported Q1 2026 results showing steady growth and strong capital. Group income rose 6% year-on-year to £8.2bn and profit before tax increased to £2.8bn. Return on tangible equity was 13.5% and basic earnings per share were 14.1p.
All divisions delivered double-digit returns, with the Investment Bank generating over £4bn of quarterly income for the first time and UK lending up 5% year-on-year. The cost:income ratio improved to 56% as operating costs grew slower than income.
Credit impairment charges increased to £823m, driving a higher loan loss rate of 74bps, including a £0.2bn single-name charge in the Investment Bank and additional management adjustments for geopolitical risk. Barclays increased its UK motor finance redress provision to £430m and now expects full-year 2026 loan losses to be around the top of its 50–60bps guidance range.
The balance sheet remained robust with a 14.1% CET1 capital ratio, £364.5bn of risk-weighted assets and tangible net asset value of 405p per share. Barclays announced a new £500m share buyback and reiterated targets of Group RoTE above 12% in 2026 and above 14% in 2028, alongside multi‑year capital return plans totalling at least £10bn for 2024‑2026 and more than £15bn for 2026‑2028.
Barclays PLC reported Q1 2026 results showing steady growth and strong capital. Group income rose 6% year-on-year to £8.2bn and profit before tax increased to £2.8bn. Return on tangible equity was 13.5% and basic earnings per share were 14.1p.
All divisions delivered double-digit returns, with the Investment Bank generating over £4bn of quarterly income for the first time and UK lending up 5% year-on-year. The cost:income ratio improved to 56% as operating costs grew slower than income.
Credit impairment charges increased to £823m, driving a higher loan loss rate of 74bps, including a £0.2bn single-name charge in the Investment Bank and additional management adjustments for geopolitical risk. Barclays increased its UK motor finance redress provision to £430m and now expects full-year 2026 loan losses to be around the top of its 50–60bps guidance range.
The balance sheet remained robust with a 14.1% CET1 capital ratio, £364.5bn of risk-weighted assets and tangible net asset value of 405p per share. Barclays announced a new £500m share buyback and reiterated targets of Group RoTE above 12% in 2026 and above 14% in 2028, alongside multi‑year capital return plans totalling at least £10bn for 2024‑2026 and more than £15bn for 2026‑2028.
Barclays PLC reports that several senior executives have reinvested their 2025 full year dividend into company equity. The transactions, all dated 9 April 2026, involved automatic dividend reinvestment into ordinary shares and American Depositary Shares rather than open-market buying.
Group Finance Director Anna Cross, senior risk, compliance and investment banking leaders, and others received small numbers of shares at around £4.0982 per share through the Barclays Group Share Incentive Plan. Group Co‑Chief Operating Officer Craig Bright also received 6,284 shares at £4.3167 via a nominee dividend reinvestment and additional shares through the incentive plan, while Denny Nealon received 1 ADS at $23.2373 under a global share purchase plan.
Barclays PLC reports that several senior executives have reinvested their 2025 full year dividend into company equity. The transactions, all dated 9 April 2026, involved automatic dividend reinvestment into ordinary shares and American Depositary Shares rather than open-market buying.
Group Finance Director Anna Cross, senior risk, compliance and investment banking leaders, and others received small numbers of shares at around £4.0982 per share through the Barclays Group Share Incentive Plan. Group Co‑Chief Operating Officer Craig Bright also received 6,284 shares at £4.3167 via a nominee dividend reinvestment and additional shares through the incentive plan, while Denny Nealon received 1 ADS at $23.2373 under a global share purchase plan.
Barclays PLC is redeeming its $2,000,000,000 5.829% Fixed‑to‑Floating Rate Resetting Senior Callable Notes due 2027 in full. The outstanding notes will be redeemed at 100% of principal plus accrued but unpaid interest from November 9, 2025 to, but excluding, May 9, 2026.
Because May 9, 2026 is not a business day, payment of the redemption price will be made on May 11, 2026, and the New York Stock Exchange listing of the notes will be cancelled on or shortly after that date. From the par redemption date, interest will cease to accrue and holders will only retain the right to receive the redemption price.
Barclays PLC is redeeming its $2,000,000,000 5.829% Fixed‑to‑Floating Rate Resetting Senior Callable Notes due 2027 in full. The outstanding notes will be redeemed at 100% of principal plus accrued but unpaid interest from November 9, 2025 to, but excluding, May 9, 2026.
Because May 9, 2026 is not a business day, payment of the redemption price will be made on May 11, 2026, and the New York Stock Exchange listing of the notes will be cancelled on or shortly after that date. From the par redemption date, interest will cease to accrue and holders will only retain the right to receive the redemption price.
Barclays PLC reports March 2026 share buy-backs, the admission of additional ordinary shares to trading, and updated total voting rights.
The company repurchased and intends to cancel ordinary shares under its buy-back programme announced on 10 February 2026, including 3,256,000 shares on 27 February 2026 and further blocks between 10 and 27 March 2026. Following successive cancellations, issued ordinary share capital with voting rights moved from 13,794,265,537 shares as of 28 February 2026 to 13,736,819,413 shares after the latest transactions. Since the programme began, Barclays has bought 105,497,346 ordinary shares on the London Stock Exchange at a volume weighted average price of 424.2590p per share.
Barclays PLC reports March 2026 share buy-backs, the admission of additional ordinary shares to trading, and updated total voting rights.
The company repurchased and intends to cancel ordinary shares under its buy-back programme announced on 10 February 2026, including 3,256,000 shares on 27 February 2026 and further blocks between 10 and 27 March 2026. Following successive cancellations, issued ordinary share capital with voting rights moved from 13,794,265,537 shares as of 28 February 2026 to 13,736,819,413 shares after the latest transactions. Since the programme began, Barclays has bought 105,497,346 ordinary shares on the London Stock Exchange at a volume weighted average price of 424.2590p per share.
Barclays PLC filed an amended Form 13F/A restating its institutional holdings disclosure. Amendment Number 3 corrects a prior submission and provides the Form 13F holdings for Q3 2025. The report lists 11,877 table entries with a reported aggregate value of $461,228,194,391. The filing was signed by Suejean Mott on 03-31-2026.
Barclays PLC filed an amended Form 13F/A restating its institutional holdings disclosure. Amendment Number 3 corrects a prior submission and provides the Form 13F holdings for Q3 2025. The report lists 11,877 table entries with a reported aggregate value of $461,228,194,391. The filing was signed by Suejean Mott on 03-31-2026.